{
     "PMID": "19429016",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090827",
     "LR": "20131121",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "453",
     "IP": "1",
     "DP": "2009 Mar 27",
     "TI": "Ghrelin protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats.",
     "PG": "58-61",
     "LID": "10.1016/j.neulet.2009.01.067 [doi]",
     "AB": "Ghrelin, a 28-amino-acid peptide, is mainly secreted by the stomach. Evidence has shown ghrelin to have neuroprotective effects. However, whether ghrelin protects hippocampal neurons against cell death in pilocarpine-induced seizures is unknown. We used Nissl staining to show that ghrelin attenuated the neuronal loss caused by pilocarpine-induced seizures in the hippocampus. Ghrelin exerted the protective action through regulating the phosphatidylinositol-3-kinase and Akt pathway. Moreover, ghrelin treatment reversed the decreased ratio of Bcl-2 to Bax induced by seizures while inhibiting the activated caspase-3. Ghrelin can inhibit hippocampal neuronal damage caused by pilocarpine-induced seizures, which might have therapeutic value in seizures.",
     "FAU": [
          "Xu, Jingjing",
          "Wang, Shuzhen",
          "Lin, Youting",
          "Cao, Lili",
          "Wang, Rong",
          "Chi, Zhaofu"
     ],
     "AU": [
          "Xu J",
          "Wang S",
          "Lin Y",
          "Cao L",
          "Wang R",
          "Chi Z"
     ],
     "AD": "Department of Neurology, Qilu Hospital, Shandong University, 44#, Wenhua Xi Road, Jinan 250012, PR China.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20090130",
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Bax protein, rat)",
          "0 (Ghrelin)",
          "0 (Neuroprotective Agents)",
          "0 (Proto-Oncogene Proteins c-bcl-2)",
          "0 (bcl-2-Associated X Protein)",
          "01MI4Q9DI3 (Pilocarpine)",
          "EC 2.7.1.- (Phosphatidylinositol 3-Kinases)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)",
          "EC 3.4.22.- (Caspase 3)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Caspase 3/metabolism",
          "Cell Death/drug effects",
          "Ghrelin/*therapeutic use",
          "Hippocampus/*drug effects/physiopathology",
          "Male",
          "Neuroprotective Agents/*therapeutic use",
          "Phosphatidylinositol 3-Kinases/metabolism",
          "Pilocarpine",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "Proto-Oncogene Proteins c-bcl-2/metabolism",
          "Pyramidal Cells/*drug effects/physiology",
          "Random Allocation",
          "Rats",
          "Rats, Wistar",
          "Seizures/chemically induced/*drug therapy",
          "Signal Transduction/drug effects",
          "bcl-2-Associated X Protein/metabolism"
     ],
     "EDAT": "2009/05/12 09:00",
     "MHDA": "2009/08/28 09:00",
     "CRDT": [
          "2009/05/12 09:00"
     ],
     "PHST": [
          "2008/12/16 00:00 [received]",
          "2009/01/25 00:00 [revised]",
          "2009/01/26 00:00 [accepted]",
          "2009/05/12 09:00 [entrez]",
          "2009/05/12 09:00 [pubmed]",
          "2009/08/28 09:00 [medline]"
     ],
     "AID": [
          "S0304-3940(09)00124-4 [pii]",
          "10.1016/j.neulet.2009.01.067 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 2009 Mar 27;453(1):58-61. doi: 10.1016/j.neulet.2009.01.067. Epub 2009 Jan 30.",
     "term": "hippocampus"
}